Acrivon Therapeutics Inc (ACRV)

Jul 27, 2026

Acrivon Therapeutics Inc (ACRV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

Jul 27, 2026

Acrivon Therapeutics Inc (ACRV) Balance Sheet - TradingKey

Jul 27, 2026

Jul 27, 2026

ACRV|Acrivon Therapeutics Inc|Price:1.570|Chg%:-0.030 - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Institutional Confidence - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026

Jul 26, 2026

Acrivon Therapeutics Inc (ACRV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 26, 2026

Jul 26, 2026

ACRV|Acrivon Therapeutics Inc|Price:1.600|Chg%:-0.070 - TradingKey

Jul 26, 2026

Jul 24, 2026

Form 4 Acrivon Therapeutics Inc For: 24 July By Investing.com - Investing.com South Africa

Jul 24, 2026

Jul 24, 2026

Acrivon Therapeutics CLO Mary Miller sells $1,008 in company stock - Investing.com

Jul 24, 2026

Jul 24, 2026

Acrivon Therapeutics CLO Mary Miller sells $1,008 in company stock By Investing.com - Investing.com Australia

Jul 24, 2026

Jul 23, 2026

Insider tax-withholding share sale at Acrivon Therapeutics (NASDAQ: ACRV) - Stock Titan

Jul 23, 2026

Jul 23, 2026

Acrivon Therapeutics (ACRV) Slips Slightly, Holding Near Key Support ZoneRegression Channel - dars.gov.et

Jul 23, 2026

Jul 22, 2026

ACRV Stock Price, Quote & Chart - ChartMill

Jul 22, 2026

Jul 22, 2026

Why Is Acrivon Therapeutics (NASDAQ:ACRV) Fueling Nasdaq Talk? - Kalkine Media

Jul 22, 2026

Jul 21, 2026

Acrivon Therapeutics (ACRV) Holds Steady Near Support Amid Low-Volume TradingVolume Spike Alerts - dars.gov.et

Jul 21, 2026

Jul 21, 2026

Acrivon highlights AP3 platform and clinical pr... - Pluang

Jul 21, 2026

Jul 21, 2026

Acrivon to Present Tumor Shrinkage and Partial Responses at AACR - Stock Titan

Jul 21, 2026

Jul 15, 2026

Trading Systems Reacting to (ACRV) Volatility - Stock Traders Daily

Jul 15, 2026

Jul 13, 2026

Acrivon Therapeutics trades below cash value de... - Pluang

Jul 13, 2026

Jul 13, 2026

Acrivon Therapeutics: Priced For Failure, Built For Precision (NASDAQ:ACRV) - Seeking Alpha

Jul 13, 2026

Jul 02, 2026

ACRVAcrivon Therapeutics Inc Options - Finviz

Jul 02, 2026

Jun 27, 2026

Price to book forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV - TradingView

Jun 27, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV - TradingView

Jun 27, 2026

Jun 26, 2026

Price to sales forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV - TradingView

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV - TradingView

Jun 26, 2026

Jun 26, 2026

Acrivon Therapeutics, Inc. Actuals & Estimates (NASDAQ:ACRV) - TradingView

Jun 26, 2026

Jun 25, 2026

ACRV Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Acrivon Therapeutics (ACRV) Slips 2.47% in Low-Volume Trade, Testing Key Support at $1.5Sector ETF Flow - dars.gov.et

Jun 25, 2026

Jun 22, 2026

Form 4 Acrivon Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 22, 2026

Director-linked RA Capital funds receive 20,275 Acrivon (ACRV) stock options at $1.52 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon (NASDAQ: ACRV) director granted 20,275 stock options at $1.52 - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon Therapeutics (ACRV) director Sharon Shacham awarded 20,275 stock options - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon Therapeutics (ACRV) director receives 20,275 stock options at $1.52 strike - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon Therapeutics (ACRV) director granted options on 20,275 shares - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon Therapeutics (ACRV) director awarded 20,275-share option for RA Capital funds - Stock Titan

Jun 22, 2026

Jun 22, 2026

Acrivon Therapeutics (ACRV) director receives 20,275 stock options at $1.52 - Stock Titan

Jun 22, 2026

Jun 18, 2026

Acrivon Shareholders Approve Expanded Equity Plan and Directors - The Globe and Mail

Jun 18, 2026

Jun 17, 2026

Acrivon Therapeutics Stockholders Approve Amended 2022 Equity Incentive Plan and Elect New Directors – June 2026 - Minichart

Jun 17, 2026

Jun 17, 2026

Acrivon Therapeutics shareholders approve equity plan changes and director elections - Investing.com UK

Jun 17, 2026

Jun 17, 2026

Acrivon Therapeutics shareholders approve equity plan changes and director elections By Investing.com - Investing.com India

Jun 17, 2026

Jun 17, 2026

Acrivon amends equity plan, shareholders approve 3,000,000-share increase - TradingView

Jun 17, 2026

Jun 17, 2026

Acrivon Therapeutics (ACRV) shareholders approve larger equity plan and elect directors - Stock Titan

Jun 17, 2026